

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of autophagic vacuole assembly (GO:2000785) | 8.46202356 |
| 2 | regulation of vacuole organization (GO:0044088) | 6.60982045 |
| 3 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 6.60873835 |
| 4 | gamma-aminobutyric acid transport (GO:0015812) | 6.50121641 |
| 5 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 6.11427949 |
| 6 | substrate-independent telencephalic tangential migration (GO:0021826) | 6.11427949 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 5.90909198 |
| 8 | lipoprotein transport (GO:0042953) | 4.93787436 |
| 9 | regulation of relaxation of muscle (GO:1901077) | 4.86832947 |
| 10 | necroptotic process (GO:0070266) | 4.54621926 |
| 11 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.36958182 |
| 12 | response to pheromone (GO:0019236) | 4.27269639 |
| 13 | DNA damage response, detection of DNA damage (GO:0042769) | 4.12952574 |
| 14 | negative regulation of stem cell proliferation (GO:2000647) | 4.10807824 |
| 15 | acylglycerol homeostasis (GO:0055090) | 3.72713817 |
| 16 | triglyceride homeostasis (GO:0070328) | 3.72713817 |
| 17 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.72450716 |
| 18 | axonal fasciculation (GO:0007413) | 3.67596952 |
| 19 | response to hydroperoxide (GO:0033194) | 3.67216505 |
| 20 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.66778839 |
| 21 | hindbrain development (GO:0030902) | 3.63678951 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.59508476 |
| 23 | L-phenylalanine catabolic process (GO:0006559) | 3.59508476 |
| 24 | positive regulation of protein depolymerization (GO:1901881) | 3.55937001 |
| 25 | oocyte maturation (GO:0001556) | 3.54302253 |
| 26 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.54301580 |
| 27 | mRNA polyadenylation (GO:0006378) | 3.52374137 |
| 28 | mitotic cell cycle arrest (GO:0071850) | 3.46501618 |
| 29 | protein K11-linked ubiquitination (GO:0070979) | 3.42807761 |
| 30 | regulation of RIG-I signaling pathway (GO:0039535) | 3.42731876 |
| 31 | multicellular organism reproduction (GO:0032504) | 3.39634774 |
| 32 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.38948440 |
| 33 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.38948440 |
| 34 | glycerophospholipid catabolic process (GO:0046475) | 3.36543960 |
| 35 | tachykinin receptor signaling pathway (GO:0007217) | 3.35340850 |
| 36 | response to ischemia (GO:0002931) | 3.34417086 |
| 37 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.32645443 |
| 38 | synaptic transmission, glutamatergic (GO:0035249) | 3.27984651 |
| 39 | S-adenosylmethionine metabolic process (GO:0046500) | 3.26330544 |
| 40 | kynurenine metabolic process (GO:0070189) | 3.25280835 |
| 41 | regulation of cholesterol homeostasis (GO:2000188) | 3.22946944 |
| 42 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.22875081 |
| 43 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.22875081 |
| 44 | aromatic amino acid family catabolic process (GO:0009074) | 3.20124307 |
| 45 | cellular response to arsenic-containing substance (GO:0071243) | 3.19063308 |
| 46 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.18896671 |
| 47 | L-phenylalanine metabolic process (GO:0006558) | 3.18896671 |
| 48 | lung secretory cell differentiation (GO:0061140) | 3.17730137 |
| 49 | mitotic sister chromatid cohesion (GO:0007064) | 3.13816352 |
| 50 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.09817648 |
| 51 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.07798860 |
| 52 | glycosphingolipid biosynthetic process (GO:0006688) | 3.07470681 |
| 53 | phospholipid translocation (GO:0045332) | 3.06053126 |
| 54 | lipid translocation (GO:0034204) | 3.06053126 |
| 55 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.05894897 |
| 56 | RNA polyadenylation (GO:0043631) | 3.05312855 |
| 57 | urea metabolic process (GO:0019627) | 3.04346991 |
| 58 | urea cycle (GO:0000050) | 3.04346991 |
| 59 | regulation of female gonad development (GO:2000194) | 3.04339721 |
| 60 | righting reflex (GO:0060013) | 3.04028748 |
| 61 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.03219959 |
| 62 | axon extension involved in axon guidance (GO:0048846) | 3.03219959 |
| 63 | indole-containing compound catabolic process (GO:0042436) | 3.01074257 |
| 64 | indolalkylamine catabolic process (GO:0046218) | 3.01074257 |
| 65 | tryptophan catabolic process (GO:0006569) | 3.01074257 |
| 66 | cellular anion homeostasis (GO:0030002) | 3.00768265 |
| 67 | negative regulation of autophagy (GO:0010507) | 2.98040532 |
| 68 | negative regulation of fibrinolysis (GO:0051918) | 2.97438280 |
| 69 | morphogenesis of embryonic epithelium (GO:0016331) | 2.94982182 |
| 70 | magnesium ion transport (GO:0015693) | 2.91984008 |
| 71 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.91899533 |
| 72 | positive regulation of synapse maturation (GO:0090129) | 2.91585991 |
| 73 | regulation of fibrinolysis (GO:0051917) | 2.91131959 |
| 74 | establishment of mitochondrion localization (GO:0051654) | 2.90115646 |
| 75 | behavioral response to nicotine (GO:0035095) | 2.89505333 |
| 76 | programmed necrotic cell death (GO:0097300) | 2.89195177 |
| 77 | piRNA metabolic process (GO:0034587) | 2.87283271 |
| 78 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.86021719 |
| 79 | mitochondrion transport along microtubule (GO:0047497) | 2.86021719 |
| 80 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.85191253 |
| 81 | acetyl-CoA metabolic process (GO:0006084) | 2.84879217 |
| 82 | telencephalon cell migration (GO:0022029) | 2.81436927 |
| 83 | growth hormone receptor signaling pathway (GO:0060396) | 2.81192487 |
| 84 | regulation of protein activation cascade (GO:2000257) | 2.80674627 |
| 85 | inactivation of MAPK activity (GO:0000188) | 2.77766145 |
| 86 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.77535654 |
| 87 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.77305101 |
| 88 | central nervous system neuron axonogenesis (GO:0021955) | 2.77287805 |
| 89 | necrotic cell death (GO:0070265) | 2.77220272 |
| 90 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.73880774 |
| 91 | branch elongation of an epithelium (GO:0060602) | 2.73745949 |
| 92 | nonmotile primary cilium assembly (GO:0035058) | 2.73507570 |
| 93 | regulation of triglyceride catabolic process (GO:0010896) | 2.72363461 |
| 94 | regulation of mononuclear cell migration (GO:0071675) | 2.72135214 |
| 95 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.70658933 |
| 96 | negative regulation of lipase activity (GO:0060192) | 2.69613387 |
| 97 | negative regulation of membrane potential (GO:0045837) | 2.69525443 |
| 98 | negative regulation of telomerase activity (GO:0051974) | 2.68573803 |
| 99 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.67499815 |
| 100 | DNA damage induced protein phosphorylation (GO:0006975) | 11.6270815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.87973546 |
| 2 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.52382319 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.92483491 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.74161897 |
| 5 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.35568013 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.19955663 |
| 7 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.19331461 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.16319619 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.11252136 |
| 10 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 2.09665064 |
| 11 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 2.04105028 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02491838 |
| 13 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.00152766 |
| 14 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.94940809 |
| 15 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.89520462 |
| 16 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88805581 |
| 17 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.85180027 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.84869219 |
| 19 | TP53_16413492_ChIP-PET_HCT116_Human | 1.81395552 |
| 20 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.80436608 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.78626614 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.78626614 |
| 23 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.77323151 |
| 24 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.64713827 |
| 25 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.64222725 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.61407023 |
| 27 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.59631273 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59057986 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.55991609 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.53315996 |
| 31 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.51908844 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.51392952 |
| 33 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.50555297 |
| 34 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.49049862 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.42328302 |
| 36 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.39251975 |
| 37 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.38067243 |
| 38 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.37826653 |
| 39 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.37186229 |
| 40 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37030522 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36874561 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.36861270 |
| 43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.36761003 |
| 44 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.35868085 |
| 45 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.34306169 |
| 46 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.34168280 |
| 47 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.33996478 |
| 48 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.32252235 |
| 49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.30730775 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30347122 |
| 51 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30068247 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25168731 |
| 53 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.24120350 |
| 54 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.23854540 |
| 55 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23439584 |
| 56 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.23138659 |
| 57 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.22226945 |
| 58 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.19842045 |
| 59 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.19300811 |
| 60 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.18598536 |
| 61 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.18385062 |
| 62 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.18218242 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.17877384 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16350569 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14225566 |
| 66 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.14216322 |
| 67 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.13236403 |
| 68 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.12250997 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11020652 |
| 70 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.10052083 |
| 71 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.09701028 |
| 72 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.09701028 |
| 73 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.07738977 |
| 74 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.06386706 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05411654 |
| 76 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02470515 |
| 77 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02403634 |
| 78 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01281041 |
| 79 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.99481632 |
| 80 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98574524 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98426839 |
| 82 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97918423 |
| 83 | FUS_26573619_Chip-Seq_HEK293_Human | 0.97484595 |
| 84 | AR_19668381_ChIP-Seq_PC3_Human | 0.97144617 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97061368 |
| 86 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96528284 |
| 87 | TBL1_22424771_ChIP-Seq_293T_Human | 0.96152876 |
| 88 | CJUN_26792858_Chip-Seq_BT549_Human | 0.95891585 |
| 89 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.95766929 |
| 90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95615262 |
| 91 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.94728510 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93116926 |
| 93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92502213 |
| 94 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.92004638 |
| 95 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.90917413 |
| 96 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89296270 |
| 97 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.88789091 |
| 98 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.88462961 |
| 99 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87641994 |
| 100 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.86525495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.29847902 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 4.23363440 |
| 3 | MP0002735_abnormal_chemical_nociception | 4.19047492 |
| 4 | MP0002736_abnormal_nociception_after | 3.81821640 |
| 5 | MP0005365_abnormal_bile_salt | 3.60823271 |
| 6 | MP0003123_paternal_imprinting | 3.58786027 |
| 7 | MP0005360_urolithiasis | 3.55591896 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 3.41919603 |
| 9 | MP0002653_abnormal_ependyma_morphology | 3.18138922 |
| 10 | MP0009840_abnormal_foam_cell | 3.03369901 |
| 11 | MP0003121_genomic_imprinting | 2.86207862 |
| 12 | MP0003656_abnormal_erythrocyte_physiolo | 2.76431357 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.74188723 |
| 14 | MP0005670_abnormal_white_adipose | 2.60986983 |
| 15 | MP0004885_abnormal_endolymph | 2.28484002 |
| 16 | MP0000778_abnormal_nervous_system | 2.13773504 |
| 17 | MP0001177_atelectasis | 2.12823501 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.09179134 |
| 19 | MP0002163_abnormal_gland_morphology | 1.89453674 |
| 20 | * MP0005551_abnormal_eye_electrophysiolog | 1.81925999 |
| 21 | MP0006292_abnormal_olfactory_placode | 1.81119711 |
| 22 | MP0003252_abnormal_bile_duct | 1.80361529 |
| 23 | MP0005379_endocrine/exocrine_gland_phen | 1.76857732 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.69304063 |
| 25 | MP0005451_abnormal_body_composition | 1.69254242 |
| 26 | MP0003718_maternal_effect | 1.67894274 |
| 27 | MP0000955_abnormal_spinal_cord | 1.55836191 |
| 28 | MP0003690_abnormal_glial_cell | 1.54909663 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52289911 |
| 30 | MP0001529_abnormal_vocalization | 1.50004735 |
| 31 | MP0000462_abnormal_digestive_system | 1.44441104 |
| 32 | MP0005083_abnormal_biliary_tract | 1.39001358 |
| 33 | MP0003329_amyloid_beta_deposits | 1.38439420 |
| 34 | MP0003122_maternal_imprinting | 1.34403921 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.33948907 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.33620811 |
| 37 | MP0000678_abnormal_parathyroid_gland | 1.24104811 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.22639068 |
| 39 | MP0005310_abnormal_salivary_gland | 1.22141862 |
| 40 | MP0003646_muscle_fatigue | 1.18962234 |
| 41 | MP0005248_abnormal_Harderian_gland | 1.14849761 |
| 42 | MP0002572_abnormal_emotion/affect_behav | 1.14603706 |
| 43 | MP0009765_abnormal_xenobiotic_induced | 1.13033191 |
| 44 | MP0003950_abnormal_plasma_membrane | 1.11458072 |
| 45 | MP0008877_abnormal_DNA_methylation | 1.08473993 |
| 46 | MP0002063_abnormal_learning/memory/cond | 1.06850607 |
| 47 | MP0003861_abnormal_nervous_system | 1.05228764 |
| 48 | MP0002282_abnormal_trachea_morphology | 1.03413489 |
| 49 | MP0003787_abnormal_imprinting | 1.02351684 |
| 50 | MP0003635_abnormal_synaptic_transmissio | 0.99877806 |
| 51 | MP0001915_intracranial_hemorrhage | 0.97953778 |
| 52 | MP0003699_abnormal_female_reproductive | 0.97753230 |
| 53 | MP0003935_abnormal_craniofacial_develop | 0.94711102 |
| 54 | MP0000537_abnormal_urethra_morphology | 0.93967542 |
| 55 | MP0010329_abnormal_lipoprotein_level | 0.93716934 |
| 56 | MP0001119_abnormal_female_reproductive | 0.91751114 |
| 57 | MP0005253_abnormal_eye_physiology | 0.90293755 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 0.88868085 |
| 59 | MP0002064_seizures | 0.88657483 |
| 60 | MP0003011_delayed_dark_adaptation | 0.88094565 |
| 61 | MP0002090_abnormal_vision | 0.87375302 |
| 62 | MP0003631_nervous_system_phenotype | 0.87210855 |
| 63 | MP0002249_abnormal_larynx_morphology | 0.87200213 |
| 64 | MP0004811_abnormal_neuron_physiology | 0.86780574 |
| 65 | MP0001286_abnormal_eye_development | 0.86495000 |
| 66 | MP0001440_abnormal_grooming_behavior | 0.85768722 |
| 67 | MP0009745_abnormal_behavioral_response | 0.85110442 |
| 68 | MP0004924_abnormal_behavior | 0.84340563 |
| 69 | MP0005386_behavior/neurological_phenoty | 0.84340563 |
| 70 | MP0000639_abnormal_adrenal_gland | 0.83350180 |
| 71 | MP0000604_amyloidosis | 0.82659576 |
| 72 | MP0002102_abnormal_ear_morphology | 0.80949458 |
| 73 | MP0000631_abnormal_neuroendocrine_gland | 0.80076700 |
| 74 | MP0005332_abnormal_amino_acid | 0.79780383 |
| 75 | MP0009763_increased_sensitivity_to | 0.79709599 |
| 76 | MP0003632_abnormal_nervous_system | 0.77789199 |
| 77 | MP0000609_abnormal_liver_physiology | 0.75482434 |
| 78 | MP0002152_abnormal_brain_morphology | 0.74659703 |
| 79 | MP0003633_abnormal_nervous_system | 0.74018312 |
| 80 | MP0003937_abnormal_limbs/digits/tail_de | 0.73925628 |
| 81 | MP0004270_analgesia | 0.73716751 |
| 82 | MP0009046_muscle_twitch | 0.73095879 |
| 83 | MP0000534_abnormal_ureter_morphology | 0.72556907 |
| 84 | MP0000653_abnormal_sex_gland | 0.72289353 |
| 85 | MP0004133_heterotaxia | 0.68336606 |
| 86 | MP0002089_abnormal_postnatal_growth/wei | 0.68196345 |
| 87 | MP0003755_abnormal_palate_morphology | 0.65849668 |
| 88 | MP0001324_abnormal_eye_pigmentation | 0.64920920 |
| 89 | MP0003195_calcinosis | 0.64248888 |
| 90 | MP0002272_abnormal_nervous_system | 0.63707736 |
| 91 | MP0002116_abnormal_craniofacial_bone | 0.62749876 |
| 92 | MP0002184_abnormal_innervation | 0.60970716 |
| 93 | MP0005187_abnormal_penis_morphology | 0.60665054 |
| 94 | MP0008874_decreased_physiological_sensi | 0.60108599 |
| 95 | * MP0002882_abnormal_neuron_morphology | 0.59932921 |
| 96 | MP0001944_abnormal_pancreas_morphology | 0.59039610 |
| 97 | MP0001970_abnormal_pain_threshold | 0.58566717 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 0.58353621 |
| 99 | MP0003942_abnormal_urinary_system | 0.57810704 |
| 100 | MP0002210_abnormal_sex_determination | 0.56476920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Peritonitis (HP:0002586) | 6.26637676 |
| 2 | Abnormality of the lower motor neuron (HP:0002366) | 5.66773804 |
| 3 | Menstrual irregularities (HP:0000858) | 4.98699305 |
| 4 | Broad palm (HP:0001169) | 4.86687042 |
| 5 | Anomalous pulmonary venous return (HP:0010772) | 4.40663563 |
| 6 | Shawl scrotum (HP:0000049) | 4.27605438 |
| 7 | Growth hormone excess (HP:0000845) | 4.25050846 |
| 8 | Oligodactyly (hands) (HP:0001180) | 4.21325549 |
| 9 | Abnormality of the pulmonary veins (HP:0011718) | 3.76900668 |
| 10 | Congenital malformation of the right heart (HP:0011723) | 3.76288552 |
| 11 | Double outlet right ventricle (HP:0001719) | 3.76288552 |
| 12 | Papillary thyroid carcinoma (HP:0002895) | 3.76154129 |
| 13 | Mild short stature (HP:0003502) | 3.75042280 |
| 14 | Deep venous thrombosis (HP:0002625) | 3.70454610 |
| 15 | Vitreoretinal degeneration (HP:0000655) | 3.60839286 |
| 16 | Overlapping toe (HP:0001845) | 3.51158722 |
| 17 | Supernumerary spleens (HP:0009799) | 3.49574497 |
| 18 | Irregular epiphyses (HP:0010582) | 3.46602319 |
| 19 | Upper motor neuron abnormality (HP:0002127) | 3.43891911 |
| 20 | Amyotrophic lateral sclerosis (HP:0007354) | 3.39898388 |
| 21 | Spontaneous abortion (HP:0005268) | 3.39853856 |
| 22 | Hepatocellular carcinoma (HP:0001402) | 3.39739087 |
| 23 | Fair hair (HP:0002286) | 3.36293566 |
| 24 | Hypoplasia of the odontoid process (HP:0003311) | 3.34316577 |
| 25 | Chorioretinal atrophy (HP:0000533) | 3.30757952 |
| 26 | Intrahepatic cholestasis (HP:0001406) | 3.28475944 |
| 27 | Broad alveolar ridges (HP:0000187) | 3.09451781 |
| 28 | Congenital stationary night blindness (HP:0007642) | 3.06425632 |
| 29 | Shoulder girdle muscle weakness (HP:0003547) | 3.03920511 |
| 30 | Large earlobe (HP:0009748) | 3.00914471 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.00822136 |
| 32 | Abnormality of lateral ventricle (HP:0030047) | 2.96085810 |
| 33 | Asplenia (HP:0001746) | 2.95965442 |
| 34 | Myocardial infarction (HP:0001658) | 2.95453331 |
| 35 | Enlarged kidneys (HP:0000105) | 2.92066792 |
| 36 | High anterior hairline (HP:0009890) | 2.90931294 |
| 37 | Abnormality of the odontoid process (HP:0003310) | 2.80304492 |
| 38 | Facial hemangioma (HP:0000329) | 2.70158810 |
| 39 | Abnormality of the peritoneum (HP:0002585) | 2.64168082 |
| 40 | Epidermoid cyst (HP:0200040) | 2.63498203 |
| 41 | Oligodactyly (HP:0012165) | 2.60960075 |
| 42 | Preauricular pit (HP:0004467) | 2.58373233 |
| 43 | Periauricular skin pits (HP:0100277) | 2.58373233 |
| 44 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.58233740 |
| 45 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.55069410 |
| 46 | Bronchomalacia (HP:0002780) | 2.52111222 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 2.48078588 |
| 48 | Hyperphosphatemia (HP:0002905) | 2.41448221 |
| 49 | Generalized hypopigmentation of hair (HP:0011358) | 2.35779899 |
| 50 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.30621592 |
| 51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.29548328 |
| 52 | Hypobetalipoproteinemia (HP:0003563) | 2.20308038 |
| 53 | Abnormality of methionine metabolism (HP:0010901) | 2.17512403 |
| 54 | Abnormality of the pubic bones (HP:0003172) | 2.15605405 |
| 55 | Rimmed vacuoles (HP:0003805) | 2.13827335 |
| 56 | Ulnar deviation of the wrist (HP:0003049) | 2.08550179 |
| 57 | Onycholysis (HP:0001806) | 2.05652476 |
| 58 | Cerebral hemorrhage (HP:0001342) | 2.05064964 |
| 59 | Agitation (HP:0000713) | 2.04275619 |
| 60 | Dislocated radial head (HP:0003083) | 2.03810298 |
| 61 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.03344452 |
| 62 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.00787392 |
| 63 | Abnormal lung lobation (HP:0002101) | 1.99724207 |
| 64 | Hypoglycemic seizures (HP:0002173) | 1.98895345 |
| 65 | Central scotoma (HP:0000603) | 1.97642975 |
| 66 | Morphological abnormality of the middle ear (HP:0008609) | 1.97469170 |
| 67 | Hyperlipoproteinemia (HP:0010980) | 1.94832243 |
| 68 | Truncus arteriosus (HP:0001660) | 1.94230787 |
| 69 | Abnormality of chromosome segregation (HP:0002916) | 1.94129943 |
| 70 | Hypochromic microcytic anemia (HP:0004840) | 1.91930165 |
| 71 | Carpal bone hypoplasia (HP:0001498) | 1.90852137 |
| 72 | Breast aplasia (HP:0100783) | 1.89853061 |
| 73 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.89225748 |
| 74 | Thyroid carcinoma (HP:0002890) | 1.89074899 |
| 75 | Fibular hypoplasia (HP:0003038) | 1.88909775 |
| 76 | Truncal obesity (HP:0001956) | 1.88586944 |
| 77 | Heterotopia (HP:0002282) | 1.88490455 |
| 78 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.88433864 |
| 79 | Hypolipoproteinemia (HP:0010981) | 1.86160206 |
| 80 | Abnormality of the radial head (HP:0003995) | 1.85414889 |
| 81 | Abolished electroretinogram (ERG) (HP:0000550) | 1.84787368 |
| 82 | Leiomyosarcoma (HP:0100243) | 1.83924919 |
| 83 | Uterine leiomyosarcoma (HP:0002891) | 1.83924919 |
| 84 | Delayed puberty (HP:0000823) | 1.82436645 |
| 85 | Hypoalphalipoproteinemia (HP:0003233) | 1.82283514 |
| 86 | Progressive cerebellar ataxia (HP:0002073) | 1.81159040 |
| 87 | Complement deficiency (HP:0004431) | 1.79003338 |
| 88 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.78287090 |
| 89 | Vertebral arch anomaly (HP:0008438) | 1.76698997 |
| 90 | Xanthomatosis (HP:0000991) | 1.76319964 |
| 91 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.75716505 |
| 92 | Hyperventilation (HP:0002883) | 1.75434694 |
| 93 | Flat acetabular roof (HP:0003180) | 1.74154440 |
| 94 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.72617346 |
| 95 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.70690815 |
| 96 | Abnormality of the nasal septum (HP:0000419) | 1.70526363 |
| 97 | Gastroesophageal reflux (HP:0002020) | 1.70408602 |
| 98 | Limb hypertonia (HP:0002509) | 1.68767122 |
| 99 | Pulmonary artery stenosis (HP:0004415) | 1.68199802 |
| 100 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.68112524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP2K6 | 5.23651909 |
| 2 | MAP3K5 | 3.51433774 |
| 3 | PNCK | 2.72194754 |
| 4 | CDK12 | 2.06221594 |
| 5 | TAOK2 | 12.7656619 |
| 6 | MAP3K8 | 1.86457713 |
| 7 | STK38L | 1.77616983 |
| 8 | WNK1 | 1.70180208 |
| 9 | DMPK | 1.54424342 |
| 10 | MAP3K6 | 1.42316775 |
| 11 | PRPF4B | 1.40028553 |
| 12 | PRKD3 | 1.35993750 |
| 13 | DDR2 | 1.29943611 |
| 14 | ERBB4 | 1.24495878 |
| 15 | LATS2 | 1.20547657 |
| 16 | BMPR1B | 1.16984353 |
| 17 | MINK1 | 1.08758497 |
| 18 | MST4 | 1.00986282 |
| 19 | LATS1 | 1.00344768 |
| 20 | CDK9 | 0.97466427 |
| 21 | TTK | 0.96354751 |
| 22 | SGK223 | 0.95928017 |
| 23 | SGK494 | 0.95928017 |
| 24 | JAK3 | 0.93310677 |
| 25 | PINK1 | 0.91822110 |
| 26 | PDPK1 | 0.91064274 |
| 27 | SGK2 | 0.85366492 |
| 28 | DYRK1B | 0.82734889 |
| 29 | MARK1 | 0.82539068 |
| 30 | PDK1 | 0.79832218 |
| 31 | TAOK3 | 0.77628003 |
| 32 | PRKD2 | 0.77134206 |
| 33 | FES | 0.75387251 |
| 34 | INSRR | 0.73918149 |
| 35 | PLK4 | 0.72516921 |
| 36 | CDK8 | 0.71547745 |
| 37 | ROCK1 | 0.70901580 |
| 38 | BRD4 | 0.70857599 |
| 39 | WEE1 | 0.68254880 |
| 40 | EPHB2 | 0.66672011 |
| 41 | CAMK2A | 0.64697875 |
| 42 | TGFBR1 | 0.57504489 |
| 43 | PLK2 | 0.56019623 |
| 44 | SGK3 | 0.52993866 |
| 45 | ZAK | 0.52019539 |
| 46 | MAP2K4 | 0.51699986 |
| 47 | STK38 | 0.50839533 |
| 48 | MUSK | 0.49440246 |
| 49 | SIK1 | 0.48412580 |
| 50 | PKN1 | 0.46150334 |
| 51 | PRKAA2 | 0.45226210 |
| 52 | FGR | 0.45116273 |
| 53 | GRK1 | 0.43731222 |
| 54 | CHEK2 | 0.40962809 |
| 55 | CDK19 | 0.40682104 |
| 56 | MAPK8 | 0.37666042 |
| 57 | PRKCH | 0.36655787 |
| 58 | SGK1 | 0.33404071 |
| 59 | TYRO3 | 0.32356778 |
| 60 | EEF2K | 0.31933261 |
| 61 | MAP3K9 | 0.30578944 |
| 62 | ROCK2 | 0.30565043 |
| 63 | STK10 | 0.30354811 |
| 64 | JAK2 | 0.28488662 |
| 65 | CAMK1D | 0.28422978 |
| 66 | PLK1 | 0.27485511 |
| 67 | EPHA2 | 0.26175870 |
| 68 | MAPK10 | 0.25826858 |
| 69 | DYRK2 | 0.24138616 |
| 70 | MAPKAPK5 | 0.24097583 |
| 71 | OXSR1 | 0.23533853 |
| 72 | PDK4 | 0.22953588 |
| 73 | PDK3 | 0.22953588 |
| 74 | YES1 | 0.22639798 |
| 75 | PLK3 | 0.22579452 |
| 76 | MAPK13 | 0.21559732 |
| 77 | CDK7 | 0.21428496 |
| 78 | PAK6 | 0.20508997 |
| 79 | CSNK1E | 0.20435843 |
| 80 | ABL2 | 0.19306157 |
| 81 | CDK1 | 0.18633307 |
| 82 | KSR1 | 0.17603295 |
| 83 | CSNK1D | 0.17419458 |
| 84 | PRKCQ | 0.17382718 |
| 85 | MAPK1 | 0.17125526 |
| 86 | KSR2 | 0.16905671 |
| 87 | PRKCB | 0.16720284 |
| 88 | NTRK1 | 0.16284346 |
| 89 | BRAF | 0.14725102 |
| 90 | CDC42BPA | 0.14637803 |
| 91 | MAPK4 | 0.14600785 |
| 92 | MATK | 0.14483426 |
| 93 | CSNK1G2 | 0.13906562 |
| 94 | PRKAA1 | 0.13905823 |
| 95 | RPS6KA3 | 0.13394604 |
| 96 | IGF1R | 0.13060154 |
| 97 | PRKCG | 0.12211156 |
| 98 | ABL1 | 0.11678098 |
| 99 | EPHA4 | 0.11193341 |
| 100 | TIE1 | 0.11049795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 6.26964762 |
| 2 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.90810159 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.85430409 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.58658697 |
| 5 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.39255066 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.38850438 |
| 7 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.28974347 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.23615636 |
| 9 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.15291000 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.07589298 |
| 11 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.06448986 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.05786596 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.98940160 |
| 14 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.83843272 |
| 15 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.79520382 |
| 16 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.70704767 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56656980 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.55345466 |
| 19 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.50502875 |
| 20 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.50414702 |
| 21 | Prion diseases_Homo sapiens_hsa05020 | 1.42185914 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41222928 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.38006237 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30793274 |
| 25 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29466884 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27571371 |
| 27 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.22664601 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.20564351 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.20186518 |
| 30 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.19676947 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.19550353 |
| 32 | Lysine degradation_Homo sapiens_hsa00310 | 1.17276511 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.16228332 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.11633336 |
| 35 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.10122759 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04067605 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.01496361 |
| 38 | Cocaine addiction_Homo sapiens_hsa05030 | 0.99930390 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95271399 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 0.95059903 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94402064 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93760124 |
| 43 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.93625983 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93012221 |
| 45 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.92813712 |
| 46 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.90327426 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 0.86461490 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.86295335 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.85693851 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84791950 |
| 51 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.83862099 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 0.81484133 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81161510 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.80989363 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80275201 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77612920 |
| 57 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.75182434 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72530455 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67538660 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66133770 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65737929 |
| 62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.65121983 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.64315541 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.63803378 |
| 65 | RNA degradation_Homo sapiens_hsa03018 | 0.63605379 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63481201 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61870953 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61136643 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59432315 |
| 70 | GABAergic synapse_Homo sapiens_hsa04727 | 0.59290524 |
| 71 | Morphine addiction_Homo sapiens_hsa05032 | 0.55732727 |
| 72 | Axon guidance_Homo sapiens_hsa04360 | 0.55178541 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53290108 |
| 74 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52748990 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50942923 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46877130 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45345985 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45162351 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44461416 |
| 80 | Cell cycle_Homo sapiens_hsa04110 | 0.43792088 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38423896 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37845038 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.37658268 |
| 84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.37496976 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36967417 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.35289007 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34870119 |
| 88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34263945 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.29911343 |
| 90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.29384121 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28082215 |
| 92 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.26565838 |
| 93 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.26068208 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26020071 |
| 95 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.24796572 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.24430148 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24327874 |
| 98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.24309834 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24129676 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23155610 |

